Ono Pharmaceutical Co., Ltd. (TYO: 4528)
Japan
· Delayed Price · Currency is JPY 1,606.00
-2.00 (-0.12%)
Dec 20, 2024, 3:45 PM JST
Ono Pharmaceutical Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 484,298 | 502,672 | 447,187 | 361,361 | 309,284 | 292,420 | Upgrade
|
| Revenue Growth (YoY) | -1.00% | 12.41% | 23.75% | 16.84% | 5.77% | 1.31% | Upgrade
|
| Cost of Revenue | 119,238 | 127,126 | 110,062 | 93,511 | 85,573 | 79,063 | Upgrade
|
| Gross Profit | 365,060 | 375,546 | 337,125 | 267,850 | 223,711 | 213,357 | Upgrade
|
| Selling, General & Admin | 108,209 | 97,389 | 86,643 | 74,119 | 66,616 | 65,196 | Upgrade
|
| Research & Development | 131,617 | 112,174 | 95,344 | 75,879 | 62,384 | 66,497 | Upgrade
|
| Other Operating Expenses | 3,215 | 2,807 | 2,250 | 4,099 | -6,626 | 1,472 | Upgrade
|
| Operating Expenses | 245,922 | 215,251 | 187,080 | 157,035 | 124,988 | 135,648 | Upgrade
|
| Operating Income | 119,138 | 160,295 | 150,045 | 110,815 | 98,723 | 77,709 | Upgrade
|
| Interest Expense | -3,583 | -125 | -89 | -84 | -105 | -105 | Upgrade
|
| Interest & Investment Income | 3,529 | 3,574 | 2,403 | 2,349 | 2,462 | 2,968 | Upgrade
|
| Earnings From Equity Investments | -1 | 1 | 4 | -6 | 4 | -4 | Upgrade
|
| Currency Exchange Gain (Loss) | 347 | 347 | -723 | -425 | 4 | -717 | Upgrade
|
| Other Non Operating Income (Expenses) | 238 | 235 | 182 | 399 | 72 | 157 | Upgrade
|
| EBT Excluding Unusual Items | 119,668 | 164,327 | 151,822 | 113,048 | 101,160 | 80,008 | Upgrade
|
| Gain (Loss) on Sale of Investments | -92 | -92 | -46 | -116 | 122 | -6 | Upgrade
|
| Gain (Loss) on Sale of Assets | -118 | -118 | -94 | -64 | -7 | 134 | Upgrade
|
| Asset Writedown | -51 | -51 | -498 | -316 | -2 | -141 | Upgrade
|
| Legal Settlements | -333 | -333 | -7,652 | -7,527 | -384 | -299 | Upgrade
|
| Pretax Income | 119,074 | 163,733 | 143,532 | 105,025 | 100,889 | 79,696 | Upgrade
|
| Income Tax Expense | 23,908 | 35,694 | 30,619 | 24,340 | 25,392 | 19,808 | Upgrade
|
| Earnings From Continuing Operations | 95,166 | 128,039 | 112,913 | 80,685 | 75,497 | 59,888 | Upgrade
|
| Minority Interest in Earnings | -39 | -62 | -190 | -166 | -72 | -184 | Upgrade
|
| Net Income | 95,127 | 127,977 | 112,723 | 80,519 | 75,425 | 59,704 | Upgrade
|
| Net Income to Common | 95,127 | 127,977 | 112,723 | 80,519 | 75,425 | 59,704 | Upgrade
|
| Net Income Growth | -23.82% | 13.53% | 40.00% | 6.75% | 26.33% | 15.84% | Upgrade
|
| Shares Outstanding (Basic) | 472 | 480 | 488 | 496 | 499 | 504 | Upgrade
|
| Shares Outstanding (Diluted) | 472 | 480 | 488 | 497 | 499 | 504 | Upgrade
|
| Shares Change (YoY) | -3.11% | -1.70% | -1.65% | -0.54% | -0.96% | -1.97% | Upgrade
|
| EPS (Basic) | 201.57 | 266.61 | 230.85 | 162.19 | 151.11 | 118.47 | Upgrade
|
| EPS (Diluted) | 201.49 | 266.57 | 230.79 | 162.16 | 151.09 | 118.45 | Upgrade
|
| EPS Growth | -21.39% | 15.50% | 42.32% | 7.33% | 27.56% | 18.17% | Upgrade
|
| Free Cash Flow | 104,346 | 106,640 | 154,270 | 56,332 | 66,959 | 66,682 | Upgrade
|
| Free Cash Flow Per Share | 221.09 | 222.15 | 315.90 | 113.45 | 134.13 | 132.29 | Upgrade
|
| Dividend Per Share | 80.000 | 80.000 | 70.000 | 56.000 | 50.000 | 45.000 | Upgrade
|
| Dividend Growth | 3.90% | 14.29% | 25.00% | 12.00% | 11.11% | 0% | Upgrade
|
| Gross Margin | 75.38% | 74.71% | 75.39% | 74.12% | 72.33% | 72.96% | Upgrade
|
| Operating Margin | 24.60% | 31.89% | 33.55% | 30.67% | 31.92% | 26.57% | Upgrade
|
| Profit Margin | 19.64% | 25.46% | 25.21% | 22.28% | 24.39% | 20.42% | Upgrade
|
| Free Cash Flow Margin | 21.55% | 21.21% | 34.50% | 15.59% | 21.65% | 22.80% | Upgrade
|
| EBITDA | 137,188 | 178,435 | 167,496 | 128,536 | 114,543 | 91,923 | Upgrade
|
| EBITDA Margin | 28.33% | 35.50% | 37.46% | 35.57% | 37.03% | 31.44% | Upgrade
|
| D&A For EBITDA | 18,050 | 18,140 | 17,451 | 17,721 | 15,820 | 14,214 | Upgrade
|
| EBIT | 119,138 | 160,295 | 150,045 | 110,815 | 98,723 | 77,709 | Upgrade
|
| EBIT Margin | 24.60% | 31.89% | 33.55% | 30.67% | 31.92% | 26.57% | Upgrade
|
| Effective Tax Rate | 20.08% | 21.80% | 21.33% | 23.18% | 25.17% | 24.85% | Upgrade
|
| Advertising Expenses | - | 24,019 | 17,837 | 11,496 | 6,903 | 5,778 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.